Financial Snapshot
Revenues
Revenues
Revenue YoY Change
Revenues
Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $18.14M | $39.02M | $10.99M | $6.914M | $6.011M | $5.945M | $10.70M | $1.491M | $23.28M | $14.95M | $15.47M | $14.11M | $16.81M | $20.73M | $12.65M | $10.99M | $14.69M | $13.98M | $12.75M | $11.25M | $2.530M | $5.090M | $3.200M | $50.00K | $550.0K | $570.0K | $290.0K | $1.220M | $820.0K |
YoY Change | -53.51% | 255.11% | 58.92% | 15.02% | 1.11% | -44.44% | 617.64% | -93.59% | 55.66% | -3.31% | 9.6% | -16.06% | -18.91% | 63.87% | 15.1% | -25.19% | 5.08% | 9.65% | 13.33% | 344.66% | -50.29% | 59.06% | 6300.0% | -90.91% | -3.51% | 96.55% | -76.23% | 48.78% |
Expenses
Cost Of Revenues
Gross Profit
Gross Profit Margin
Gross Profit
Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $18.14M | $39.02M | $10.99M | $6.914M | $6.011M | $5.945M | $10.70M | $1.491M | $23.28M | $14.95M | $15.47M | $14.11M | $16.81M | $20.73M | $12.65M | $10.99M | $14.69M | $13.98M | $12.75M | $11.25M | $2.530M | $5.090M | $3.200M | $50.00K | $550.0K | $570.0K | $290.0K | $1.220M | $820.0K |
Cost Of Revenue | |||||||||||||||||||||||||||||
Gross Profit | |||||||||||||||||||||||||||||
Gross Profit Margin |
Selling, General & Admin Expense
Research & Development
Depreciation, Depletion & Amortization
SGA Expense to Gross Profit Ratio
R&D To Gross Profit Ratio
DDA To Gross Profit Ratio
Operating Expenses Total
Operating Profits/Loss
Operational Expenses
Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General & Admin | $22.48M | $17.83M | $17.14M | $14.72M | $17.73M | $16.00M | $16.13M | $39.44M | $26.44M | $8.680M | $5.550M | $8.140M | $6.390M | $4.640M | $3.640M | $4.130M | $4.100M | $3.960M | $3.630M | $7.170M | $6.290M | $6.000M | $3.050M | $2.020M | $1.530M | $1.380M | $1.320M | $900.0K | $510.0K |
YoY Change | 26.02% | 4.07% | 16.41% | -16.98% | 10.81% | -0.81% | -59.1% | 49.17% | 204.61% | 56.4% | -31.82% | 27.39% | 37.72% | 27.47% | -11.86% | 0.73% | 3.54% | 9.09% | -49.37% | 13.99% | 4.83% | 96.72% | 50.99% | 32.03% | 10.87% | 4.55% | 46.67% | 76.47% | |
% of Gross Profit | |||||||||||||||||||||||||||||
Research & Development | $73.70M | $84.41M | $65.50M | $49.34M | $57.60M | $57.93M | $62.68M | $61.25M | $51.51M | $38.71M | $21.46M | $18.04M | $20.13M | $21.48M | $15.58M | $15.11M | $7.780M | $4.650M | $8.400M | $20.63M | $21.97M | $23.11M | $13.08M | $7.530M | $7.560M | $8.980M | $6.490M | $4.970M | $1.830M |
YoY Change | -12.69% | 28.86% | 32.76% | -14.35% | -0.57% | -7.57% | 2.32% | 18.93% | 33.04% | 80.41% | 18.95% | -10.38% | -6.28% | 37.87% | 3.11% | 94.22% | 67.31% | -44.64% | -59.28% | -6.1% | -4.93% | 76.68% | 73.71% | -0.4% | -15.81% | 38.37% | 30.58% | 171.58% | |
% of Gross Profit | |||||||||||||||||||||||||||||
Depreciation & Amortization | $1.400M | $1.400M | $1.800M | $2.000M | $2.028M | $2.181M | $2.027M | $1.092M | $589.0K | $529.0K | $613.0K | $870.0K | $990.0K | $1.010M | $870.0K | $720.0K | $380.0K | $740.0K | $1.740M | $5.060M | $6.380M | $5.670M | $4.030M | $1.340M | $1.340M | $1.100M | $700.0K | $510.0K | $230.0K |
YoY Change | 0.0% | -22.22% | -10.0% | -1.38% | -7.02% | 7.6% | 85.62% | 85.4% | 11.34% | -13.7% | -29.54% | -12.12% | -1.98% | 16.09% | 20.83% | 89.47% | -48.65% | -57.47% | -65.61% | -20.69% | 12.52% | 40.69% | 200.75% | 0.0% | 21.82% | 57.14% | 37.25% | 121.74% | |
% of Gross Profit | |||||||||||||||||||||||||||||
Operating Expenses | $96.24M | $104.5M | $84.51M | $64.72M | $149.9M | $95.73M | $121.6M | $493.1M | $127.2M | $48.39M | $27.62M | $27.05M | $27.51M | $27.14M | $20.08M | $19.95M | $12.25M | $9.350M | $13.79M | $32.87M | $34.64M | $34.79M | $20.16M | $10.90M | $9.080M | $10.36M | $7.810M | $5.870M | $2.340M |
YoY Change | -7.88% | 23.62% | 30.58% | -56.83% | 56.61% | -21.3% | -75.34% | 287.7% | 162.87% | 75.21% | 2.1% | -1.67% | 1.36% | 35.16% | 0.65% | 62.86% | 31.02% | -32.2% | -58.05% | -5.11% | -0.43% | 72.57% | 84.95% | 20.04% | -12.36% | 32.65% | 33.05% | 150.85% | |
Operating Profit | -$78.10M | -$65.46M | -$73.52M | -$57.81M | -$143.9M | -$89.78M | -$110.9M | -$491.6M | -$103.9M | -$33.43M | -$12.15M | ||||||||||||||||||
YoY Change | 19.32% | -10.97% | 27.19% | -59.83% | 60.28% | -19.07% | -77.44% | 373.1% | 210.82% | 175.13% |
Interest Expenses
Interest Expenses To Operating Income %
Other Expense/Income
Interest & Other Expense/Income
Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Interest Expense | $459.0K | $1.726M | $2.857M | $4.011M | $2.108M | $226.0K | $261.0K | $0.00 | $0.00 | -$5.400M | -$1.910M | -$3.660M | $690.0K | $100.0K | -$240.0K | $2.770M | -$40.00K | -$1.330M | -$2.560M | -$2.310M | -$1.720M | $2.130M | $2.070M | $1.510M | $870.0K | $1.260M | $210.0K | ||
YoY Change | -73.41% | -39.59% | -28.77% | 90.28% | 832.74% | -13.41% | -100.0% | 182.72% | -47.81% | -630.43% | 590.0% | -141.67% | -108.66% | -7025.0% | -96.99% | -48.05% | 10.82% | 34.3% | -180.75% | 2.9% | 37.09% | -30.95% | 500.0% | ||||||
% of Operating Profit | |||||||||||||||||||||||||||||
Other Income/Expense, Net | $5.254M | $444.0K | -$2.725M | -$5.939M | -$22.48M | $28.44M | $2.197M | $2.473M | $25.02M | -$5.403M | -$1.911M | -$50.00K | -$80.00K | $0.00 | $24.34M | $1.110M | $1.930M | $5.460M | -$100.0K | $550.0K | $50.00K | $560.0K | $700.0K | ||||||
YoY Change | 1083.33% | -116.29% | -54.12% | -73.58% | -179.04% | 1194.4% | -11.16% | -90.11% | -563.0% | 182.73% | 3722.0% | -37.5% | 2092.79% | -42.49% | -64.65% | -5560.0% | -118.18% | 1000.0% | -91.07% | -20.0% |
Income/Loss
Pretax Income
Income Tax
Net Profits/Loss
Pretax Income YoY Change
Income Tax Rate
Net Profits/Loss YoY Change
Basic EPS
Net Income To Revenue Ratio
Pretax & Net Income
Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pretax Income | -$14.80M | -$28.70M | -$7.700M | -$63.75M | -$166.4M | -$61.34M | -$108.7M | -$489.2M | -$78.90M | -$38.84M | -$14.06M | $29.61M | -$10.08M | -$12.05M | -$7.670M | -$28.04M | -$2.430M | $18.58M | -$7.360M | -$25.93M | -$28.37M | -$27.67M | -$14.33M | -$9.300M | -$7.970M | -$9.080M | -$6.650M | -$3.400M | -$1.310M |
YoY Change | -48.43% | 272.73% | -87.92% | -61.69% | 171.23% | -43.58% | -77.77% | 519.96% | 103.16% | 176.16% | -147.49% | -393.75% | -16.35% | 57.11% | -72.65% | 1053.91% | -113.08% | -352.45% | -71.62% | -8.6% | 2.53% | 93.09% | 54.09% | 16.69% | -12.22% | 36.54% | 95.59% | 159.54% | |
Income Tax | $0.00 | $4.444M | $0.00 | $0.00 | -$12.66M | -$4.282M | -$24.32M | -$105.0M | -$16.19M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $370.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
% Of Pretax Income | 0.0% | 0.0% | |||||||||||||||||||||||||||
Net Earnings | -$72.85M | -$69.46M | -$76.25M | -$63.75M | -$153.7M | -$57.06M | -$84.41M | -$384.2M | -$62.72M | -$38.84M | -$14.06M | $29.61M | -$10.08M | -$12.05M | -$7.670M | -$28.04M | -$2.430M | $18.58M | -$7.730M | -$25.93M | -$28.37M | -$28.78M | -$14.41M | -$9.300M | -$7.970M | -$9.080M | -$6.650M | -$3.400M | -$1.310M |
YoY Change | 4.89% | -8.91% | 19.61% | -58.53% | 169.41% | -32.4% | -78.03% | 512.53% | 61.49% | 176.16% | -147.49% | -393.75% | -16.35% | 57.11% | -72.65% | 1053.91% | -113.08% | -340.36% | -70.19% | -8.6% | -1.42% | 99.72% | 54.95% | 16.69% | -12.22% | 36.54% | 95.59% | 159.54% | |
Net Earnings / Revenue | -401.57% | -178.01% | -693.91% | -921.97% | -2557.36% | -959.8% | -788.91% | -25765.53% | -269.45% | -259.73% | -90.93% | 209.85% | -59.96% | -58.13% | -60.63% | -255.14% | -16.54% | 132.9% | -60.63% | -230.49% | -1121.34% | -565.42% | -450.31% | -18600.0% | -1449.09% | -1592.98% | -2293.1% | -278.69% | -159.76% |
Basic Earnings Per Share | -$0.44 | -$0.46 | -$0.83 | -$1.00 | -$1.21 | -$1.56 | -$7.24 | -$1.38 | -$1.80 | -$0.92 | |||||||||||||||||||
Diluted Earnings Per Share | -$0.44 | -$0.46 | -$0.83 | -$1.00 | -$2.693M | -$1.21 | -$1.56 | -$7.24 | -$1.38 | -$1.80 | -$0.92 | $2.068M | -$890.5K | -$1.167M | -$742.5K | -$3.453M | -$509.4K | $4.813M | -$2.003M | -$6.735M | -$7.969M | -$8.748M | -$5.438M | -$3.765M | -$5.652M | -$8.407M | -$6.786M | -$4.000M | -$2.911M |
Assets & Liabilities
Cash & Short-Term Investments
Cash & Equivalents
Cash To Operating Expenses Ratio
Inventory
Receivables
Total Short-Term Assets
Property, Plant And Equipment
Long-Term Investments
Total Long-Term Assets
Total Assets
Net Income To Total Assets Percentage
Accounts Payable
Short-Term Debt
Long Term Debt Due
Total Short-Term Liabilities
Long-Term Debt
Other Long-Term Liabilities
Total Long-Term Liabilities
Total Liabilities
Short-Term To Long-Term Debt Ratio
Short-Term Assets To Debt Ratio
Long-Term Debt To Net Income Ratio
Assets & Liabilities
Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Short-Term Investments | $126.0M | $146.9M | $155.3M | $123.3M | $90.80M | $124.6M | $126.4M | $130.6M | $181.3M | $112.2M | $68.70M | $47.00M | $9.000M | $12.40M | $23.20M | $26.30M | $21.00M | $4.900M | $10.50M | $25.00M | $39.20M | $38.20M | $47.60M | $24.00M | $19.70M | $6.500M | $18.60M | $26.20M | $9.100M |
YoY Change | -14.23% | -5.41% | 25.97% | 35.79% | -27.13% | -1.42% | -3.22% | -27.96% | 61.59% | 63.32% | 46.17% | 422.22% | -27.42% | -46.55% | -11.79% | 25.24% | 328.57% | -53.33% | -58.0% | -36.22% | 2.62% | -19.75% | 98.33% | 21.83% | 203.08% | -65.05% | -29.01% | 187.91% | |
Cash & Equivalents | $26.29M | $30.78M | $109.3M | $52.30M | $31.80M | $36.90M | $54.30M | $23.40M | $166.8M | $72.20M | $68.70M | $47.00M | $9.000M | $12.40M | $23.20M | $21.60M | $21.00M | $4.900M | $10.50M | $25.00M | $35.60M | $20.50M | $25.60M | $2.000M | $10.90M | $800.0K | $18.60M | $26.20M | $9.100M |
Short-Term Investments | $99.72M | $116.1M | $46.04M | $71.00M | $59.00M | $87.70M | $72.10M | $107.1M | $14.50M | $40.00M | $4.700M | $0.00 | $0.00 | $3.600M | $17.70M | $21.90M | $21.90M | $8.700M | $5.700M | ||||||||||
Other Short-Term Assets | $4.248M | $2.874M | $4.445M | $3.100M | $1.800M | $2.800M | $2.100M | $1.300M | $1.200M | $1.700M | $1.300M | $700.0K | $1.400M | $1.700M | $200.0K | $100.0K | $100.0K | $100.0K | $200.0K | $2.000M | $500.0K | $200.0K | $200.0K | $200.0K | $100.0K | $100.0K | $200.0K | $200.0K | $100.0K |
YoY Change | 47.81% | -35.34% | 43.39% | 72.22% | -35.71% | 33.33% | 61.54% | 8.33% | -29.41% | 30.77% | 85.71% | -50.0% | -17.65% | 750.0% | 100.0% | 0.0% | 0.0% | -50.0% | -90.0% | 300.0% | 150.0% | 0.0% | 0.0% | 100.0% | 0.0% | -50.0% | 0.0% | 100.0% | |
Inventory | $0.00 | $200.0K | $0.00 | $100.0K | $200.0K | $0.00 | $0.00 | $200.0K | $0.00 | ||||||||||||||||||||
Prepaid Expenses | |||||||||||||||||||||||||||||
Receivables | $1.776M | $1.352M | $899.0K | $1.300M | $1.200M | $1.400M | $500.0K | $400.0K | $1.100M | $2.400M | $300.0K | $3.400M | $900.0K | $3.300M | $1.000M | $500.0K | $1.800M | $600.0K | $300.0K | $1.800M | $300.0K | $500.0K | $1.700M | $100.0K | $200.0K | $200.0K | $500.0K | $200.0K | $100.0K |
Other Receivables | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $400.0K | $400.0K | $300.0K | $300.0K | $100.0K | $100.0K | $100.0K | $300.0K | $400.0K | $300.0K | $400.0K | $0.00 | $0.00 | $0.00 | $0.00 | $100.0K | $0.00 | $300.0K | $700.0K | $300.0K | $0.00 | $0.00 | $700.0K | $600.0K |
Total Short-Term Assets | $132.0M | $151.1M | $160.7M | $127.7M | $93.80M | $129.2M | $129.4M | $132.6M | $183.9M | $116.4M | $70.30M | $51.20M | $11.60M | $18.00M | $24.70M | $27.30M | $23.20M | $5.500M | $10.90M | $28.70M | $40.10M | $38.90M | $49.80M | $25.20M | $20.30M | $6.900M | $19.30M | $27.30M | $9.800M |
YoY Change | -12.65% | -5.93% | 25.81% | 36.14% | -27.4% | -0.15% | -2.41% | -27.9% | 57.99% | 65.58% | 37.3% | 341.38% | -35.56% | -27.13% | -9.52% | 17.67% | 321.82% | -49.54% | -62.02% | -28.43% | 3.08% | -21.89% | 97.62% | 24.14% | 194.2% | -64.25% | -29.3% | 178.57% | |
Property, Plant & Equipment | $6.090M | $6.814M | $8.075M | $9.300M | $11.40M | $10.10M | $12.20M | $6.900M | $3.200M | $1.800M | $1.400M | $1.400M | $2.200M | $3.100M | $3.200M | $1.600M | $1.500M | $500.0K | $1.000M | $3.400M | $4.100M | $3.700M | $2.800M | $2.400M | $2.900M | $3.000M | $3.000M | $1.300M | $500.0K |
YoY Change | -10.63% | -15.62% | -13.17% | -18.42% | 12.87% | -17.21% | 76.81% | 115.63% | 77.78% | 28.57% | 0.0% | -36.36% | -29.03% | -3.13% | 100.0% | 6.67% | 200.0% | -50.0% | -70.59% | -17.07% | 10.81% | 32.14% | 16.67% | -17.24% | -3.33% | 0.0% | 130.77% | 160.0% | |
Goodwill | |||||||||||||||||||||||||||||
YoY Change | |||||||||||||||||||||||||||||
Intangibles | |||||||||||||||||||||||||||||
YoY Change | |||||||||||||||||||||||||||||
Long-Term Investments | $6.284M | $37.36M | $35.69M | $0.00 | $22.20M | $0.00 | $0.00 | $10.10M | $0.00 | $600.0K | $1.500M | $2.100M | $2.200M | $200.0K | $200.0K | $200.0K | $200.0K | $0.00 | |||||||||||
YoY Change | -83.18% | 4.69% | -100.0% | -100.0% | -100.0% | -60.0% | -28.57% | -4.55% | 1000.0% | 0.0% | 0.0% | 0.0% | |||||||||||||||||
Other Assets | $0.00 | $103.0K | $61.00K | $0.00 | $300.0K | $0.00 | $12.60M | $12.60M | $0.00 | $1.200M | $200.0K | $0.00 | |||||||||||||||||
YoY Change | -100.0% | 68.85% | -100.0% | -100.0% | 0.0% | -100.0% | 500.0% | ||||||||||||||||||||||
Total Long-Term Assets | $12.37M | $44.28M | $43.82M | $9.400M | $11.70M | $98.70M | $107.8M | $143.3M | $528.4M | $1.800M | $1.400M | $1.400M | $2.100M | $3.100M | $3.100M | $15.10M | $1.500M | $500.0K | $7.600M | $12.40M | $10.60M | $14.40M | $17.80M | $7.300M | $8.600M | $9.000M | $3.200M | $1.300M | $600.0K |
YoY Change | -72.06% | 1.04% | 366.21% | -19.66% | -88.15% | -8.44% | -24.77% | -72.88% | 29255.56% | 28.57% | 0.0% | -33.33% | -32.26% | 0.0% | -79.47% | 906.67% | 200.0% | -93.42% | -38.71% | 16.98% | -26.39% | -19.1% | 143.84% | -15.12% | -4.44% | 181.25% | 146.15% | 116.67% | |
Total Assets | $144.4M | $195.4M | $204.5M | $137.1M | $105.5M | $227.9M | $237.2M | $275.9M | $712.3M | $118.2M | $71.70M | $52.60M | $13.70M | $21.10M | $27.80M | $42.40M | $24.70M | $6.000M | $18.50M | $41.10M | $50.70M | $53.30M | $67.60M | $32.50M | $28.90M | $15.90M | $22.50M | $28.60M | $10.40M |
YoY Change | |||||||||||||||||||||||||||||
Accounts Payable | $3.223M | $3.520M | $3.174M | $3.000M | $2.400M | $3.200M | $2.000M | $3.200M | $2.600M | $2.000M | $1.200M | $800.0K | $1.300M | $3.000M | $2.000M | $500.0K | $300.0K | $300.0K | $200.0K | $8.300M | $3.700M | $4.300M | $2.500M | $1.800M | $1.200M | $800.0K | $1.100M | $300.0K | $500.0K |
YoY Change | -8.44% | 10.9% | 5.8% | 25.0% | -25.0% | 60.0% | -37.5% | 23.08% | 30.0% | 66.67% | 50.0% | -38.46% | -56.67% | 50.0% | 300.0% | 66.67% | 0.0% | 50.0% | -97.59% | 124.32% | -13.95% | 72.0% | 38.89% | 50.0% | 50.0% | -27.27% | 266.67% | -40.0% | |
Accrued Expenses | $7.473M | $12.88M | $8.021M | $6.300M | $5.200M | $7.600M | $8.600M | $6.300M | $5.900M | $7.000M | $2.400M | $2.900M | $2.400M | $2.800M | $2.900M | $2.900M | $1.400M | $1.200M | $1.400M | ||||||||||
YoY Change | -41.98% | 60.59% | 27.32% | 21.15% | -31.58% | -11.63% | 36.51% | 6.78% | -15.71% | 191.67% | -17.24% | 20.83% | -14.29% | -3.45% | 0.0% | 107.14% | 16.67% | -14.29% | |||||||||||
Deferred Revenue | |||||||||||||||||||||||||||||
YoY Change | |||||||||||||||||||||||||||||
Short-Term Debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
YoY Change | |||||||||||||||||||||||||||||
Long-Term Debt Due | $100.0K | $100.0K | $0.00 | $800.0K | $400.0K | $100.0K | $100.0K | $100.0K | $0.00 | $0.00 | |||||||||||||||||||
YoY Change | 0.0% | -100.0% | 100.0% | 300.0% | 0.0% | 0.0% | |||||||||||||||||||||||
Total Short-Term Liabilities | $22.49M | $32.86M | $11.22M | $9.500M | $7.800M | $11.20M | $14.60M | $10.60M | $10.60M | $20.20M | $12.50M | $11.00M | $6.900M | $8.200M | $6.500M | $4.100M | $6.400M | $5.800M | $2.200M | $11.00M | $4.500M | $4.800M | $2.900M | $1.900M | $1.200M | $800.0K | $1.100M | $400.0K | $800.0K |
YoY Change | -31.56% | 192.82% | 18.12% | 21.79% | -30.36% | -23.29% | 37.74% | 0.0% | -47.52% | 61.6% | 13.64% | 59.42% | -15.85% | 26.15% | 58.54% | -35.94% | 10.34% | 163.64% | -80.0% | 144.44% | -6.25% | 65.52% | 52.63% | 58.33% | 50.0% | -27.27% | 175.0% | -50.0% | |
Long-Term Debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $12.00M | $12.00M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $100.0K | $100.0K | $1.000M | $800.0K | $200.0K | $200.0K | $100.0K | $100.0K | $0.00 | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | 0.0% | -100.0% | 0.0% | -90.0% | 25.0% | 300.0% | 0.0% | 100.0% | 0.0% | |||||||||||||||||||
Other Long-Term Liabilities | $15.90M | $25.71M | $23.83M | $25.60M | $25.00M | $3.800M | $11.10M | $9.100M | $7.700M | $9.900M | $0.00 | $700.0K | $1.700M | $2.200M | $0.00 | $0.00 | $34.70M | $39.60M | $30.30M | $2.900M | $3.000M | $500.0K | $600.0K | $600.0K | $700.0K | $0.00 | |||
YoY Change | -38.17% | 7.91% | -6.93% | 2.4% | 557.89% | -65.77% | 21.98% | 18.18% | -22.22% | -100.0% | -58.82% | -22.73% | -100.0% | -12.37% | 30.69% | 944.83% | -3.33% | 500.0% | -16.67% | 0.0% | -14.29% | ||||||||
Total Long-Term Liabilities | $15.90M | $25.71M | $23.83M | $25.60M | $25.00M | $3.800M | $23.10M | $21.10M | $7.700M | $9.900M | $0.00 | $700.0K | $1.700M | $2.200M | $0.00 | $0.00 | $0.00 | $100.0K | $34.80M | $40.60M | $31.10M | $3.100M | $3.200M | $600.0K | $700.0K | $600.0K | $700.0K | $0.00 | $0.00 |
YoY Change | -38.17% | 7.91% | -6.93% | 2.4% | 557.89% | -83.55% | 9.48% | 174.03% | -22.22% | -100.0% | -58.82% | -22.73% | -100.0% | -99.71% | -14.29% | 30.55% | 903.23% | -3.13% | 433.33% | -14.29% | 16.67% | -14.29% | |||||||
Total Liabilities | $38.38M | $58.57M | $35.05M | $35.10M | $32.80M | $27.70M | $54.70M | $72.90M | $164.6M | $30.10M | $12.50M | $11.70M | $8.500M | $10.30M | $6.500M | $4.100M | $6.400M | $5.900M | $37.00M | $51.60M | $35.70M | $7.900M | $6.100M | $2.500M | $1.900M | $1.400M | $1.800M | $400.0K | $800.0K |
YoY Change | -34.46% | 67.11% | -0.15% | 7.01% | 18.41% | -49.36% | -24.97% | -55.71% | 446.84% | 140.8% | 6.84% | 37.65% | -17.48% | 58.46% | 58.54% | -35.94% | 8.47% | -84.05% | -28.29% | 44.54% | 351.9% | 29.51% | 144.0% | 31.58% | 35.71% | -22.22% | 350.0% | -50.0% |
Ownership
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares
Stock Issuance & Repurchase
Ownership Data
Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Basic Shares Outstanding | 166.0M shares | 150.9M shares | 106.2M shares | 75.84M shares | 55.30M shares | 54.72M shares | 53.07M shares | 45.46M shares | 21.60M shares | 15.30M shares | |||||||||||||||||||
Diluted Shares Outstanding | 166.0M shares | 150.9M shares | 106.2M shares | 75.84M shares | 55.30M shares | 54.72M shares | 53.07M shares | 45.46M shares | 21.60M shares | 15.30M shares | |||||||||||||||||||
Preferred Stock | |||||||||||||||||||||||||||||
Treasury Stock Shares |
Return On Shareholders' Equity
Book Value
Free Cash Flow
Free Cash Flow YoY
Free Cash Flow Margin
Dividends
Dividends
Stock Price
About Arbutus Biopharma Corp
Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. The company is headquartered in Warminster, Pennsylvania and currently employs 73 full-time employees. The company went IPO on 2010-11-13. The firm is leveraging its virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can potentially be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV) infection. Its HBV product pipeline includes Imdusiran and AB-101. Imdusiran is its proprietary, conjugated GalNAc, subcutaneously delivered RNAi therapeutic product candidate. AB-101 is an oral PD-L1 inhibitor that has the potential to reawaken patients’ HBV-specific immune response by inhibiting PD-L1. Its pipeline includes two product candidates that target various steps in the HBV viral lifecycle and consists of various programs: RNAi therapeutic (imdusiran, AB-729) and Oral PD-L1 Inhibitor (AB-101). RNAi therapeutics utilize a natural pathway within cells to silence genes by eliminating the disease-causing proteins that they code for.
Industry: Pharmaceutical Preparations Peers: Annexon, Inc. Tango Therapeutics, Inc. BioAtla, Inc. Biomea Fusion, Inc. CONCERT PHARMACEUTICALS, INC. GreenLight Biosciences Holdings, PBC SUTRO BIOPHARMA, INC. Immuneering Corp Omega Therapeutics, Inc.